Ironwood Pharmaceuticals Inc (IRWD)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

100 SUMMER STREET, SUITE 2300 BOSTON, MA 02110

Ironwood Pharmaceuticals, Inc. discovers, develops, and commercializes medicines targeting therapeutic needs. The company is developing Linaclotide, a first-in-class compound that is in confirmatory Phase III clinical trials for the treatment of irritable bowel syndrome with constipation, chronic constipation, and other lower gastrointestinal conditions. It also focuses on one Phase I pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. The company has a collaboration agreement with Forest Laboratories, Inc. to jointly develop and commercialize linaclotide in North America; a license agreement with Almirall, S.A. to develop and commercialize linaclotide in Europe; a license agreement with Astellas Pharma Inc. that provides Astellas Pharma with the right to develop and commercialize linaclotide in Japan, South Korea, Taiwan, Thailand, the Philippines, and Indonesia. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.

Data as of 2021-04-17 10:18:58 -0400
Market Cap1.708 Billion Shares Outstanding160.962 Million Avg 30-day Volume1.759 Million
P/E Ratio16.0847 Dividend Yield0.0 EPS0.661
Price/Sales4.21 Debt to Equity8.93 EBITDA161.886 Million
Price to Book Value26.18 Forward PE10.61 Enterprise Value1.708 Billion
Total Cash362.564 Million Current Debt32.173 Million Gross Profit386.387 Million
BETA0.69731 52-week High/Low12.55 / 8.63 Next Earnings Date2021-05-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from IRWD instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 2 50.0% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 201 189 6.35% 63 (3.79%) 62 (3.86%) 1.61%
13F shares: 171.051 Million 169.856 Million 0.7% 78.782 Million 73.273 Million 7.52%
% Ownership 49.2087 45.7679 7.52%
New Positions: 40 24 66.67% 13 10 30.0%
Increased Positions 67 67 0.0% 26 23 13.04%
Closed Positions 28 36 -22.22% 12 17 -29.41%
Reduced Positions 61 64 -4.69% 20 22 -9.09%
Total Calls 1.295 Million 1.355 Million -4.39% 108.6 Thousand 500 Thousand -78.28%
Total Puts 559.566 Thousand 621.543 Thousand -9.97% 542.5 Thousand 538.3 Thousand 0.78%
PUT/CALL Ratio 0.43 0.46 -6.52% 5.0 1.08 362.96%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IRWD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IRWD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

2.4 Million total shares from 11 transactions

Open Market Sells (S)

88.8 Thousand total shares from 19 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCHUGH JULIE

  • Director
125,607 2021-04-20 3

MCCOURT THOMAS A PRESIDENT AND INTERIM CEO

  • Officer
568,215 2021-03-26 5

CONSYLMAN GINA SVP, CFO & TREASURER

  • Officer
392,616 2021-03-26 4

RICKARD JASON SVP, CHIEF OPERATING OFFICER

  • Officer
363,054 2021-03-26 6

SHETZLINE MICHAEL CMO, SVP & HEAD OF DRUG DEVT.

  • Officer
199,514 2021-03-26 4

DREYFUS ANDREW

  • Director
109,097 2021-03-15 5

MOUKHEIBIR CATHERINE

  • Director
48,994 2021-03-15 2

DENNER ALEXANDER J

SARISSA CAPITAL MANAGEMENT LP

  • Director
  • 10% Owner
16,429,079 2021-03-15 7

OWENS EDWARD P

  • Director
258,954 2021-02-26 3

MALLON MARK CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
470,605 2021-02-26 2

KILROY CONOR SVP, GC & SECRETARY

  • Officer
122,336 2021-02-26 4

DENNER ALEXANDER J

  • Director
15,427,844 2021-02-26 7

MACDONALD KELLY CHIEF ACCOUNTING OFFICER

  • Officer
93,041 2020-12-04 6

SHEPARD JAY

  • Director
35,557 2020-12-03 2

OLANOFF LAWRENCE S

  • Director
68,629 2020-06-10 2

CURRIE MARK G

  • Director
570,992 2020-06-03 1

DUANE JON R

  • Director
47,421 2020-06-03 1

KESSLER MARLA L

  • Director
47,421 2020-06-03 1

GILBERT HALLEY E CHIEF ADMIN OFFICER & SVP

  • Officer
265,991 2020-02-21 0

MCGUIRE TERRANCE

  • Director
144,373 2019-04-01 0

HECHT PETER M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-04-01 0

FANUCCI MARSHA

  • Director
132,663 2019-04-01 0

WILLIAMS DOUGLAS E

  • Director
87,800 2019-04-01 0

SCHULMAN AMY W

  • Director
38,242 2019-04-01 0

HUYETT WILLIAM CHIEF OPERATING OFFICER

  • Officer
27,546 2019-04-01 0

WALSH CHRISTOPHER T PHD

  • Director
374,525 2017-03-15 0

GRANEY THOMAS CHIEF FINANCIAL OFFICER

  • Officer
42,013 2017-02-27 0

ROBERTS BRYAN E

  • Director
123,978 2015-06-15 0

CONRADES GEORGE H

  • Director
635,976 2015-06-03 0

EBERSMAN DAVID A

  • Director
101,233 2015-03-13 0

COOK JOSEPH C JR

  • Director
328,080 2015-03-11 0

HIGGINS MICHAEL J CHIEF OPERATING OFFICER

  • Officer
329,102 2014-12-23 0

SHAW DAVID EVANS

  • Director
393,455 2014-03-14 0

FMR LLC

FIL LTD

  • EDWARD C. JOHNSON 3DEDWARD C. JOHNSON 3D
No longer subject to file 2013-03-28 0

VENROCK ASSOCIATES

VENROCK ASSOCIATES II LP

VENROCK ENTERPRENEURS FUND LP

VR MANAGEMENT LLC

  • 10% Owner
No longer subject to file 2013-03-15 0

VHCP CO-INVESTMENT HOLDINGS, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP MANAGEMENT, LLC

VENROCK ASSOCIATES V LP

VENROCK PARTNERS V L P

VENROCK MANAGEMENT V, LLC

VENROCK PARTNERS MANAGEMENT V, LLC

HOVE ANDERS D

  • 10% Owner
No longer subject to file 2013-03-15 0

FMR LLC

  • 10% Owner
  • EDWARD C. JOHNSON 3D
2,340,891 2012-07-09 0

RIDGEBACK CAPITAL INVESTMENTS L.P.

RIDGEBACK CAPITAL INVESTMENTS LTD.

RIDGEBACK CAPITAL MANAGEMENT LP

  • 10% Owner
No longer subject to file 2012-02-02 0

VR MANAGEMENT LLC

  • 10% Owner
42,667 2011-03-31 0

VENROCK ASSOCIATES

VENROCK ASSOCIATES II LP

VENROCK ENTERPRENEURS FUND LP

VENROCK MANAGEMENT LLC

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

VR MANAGEMENT LLC

HOVE ANDERS D

  • 10% Owner
8,731,321 2010-02-02 0

MILLER GINA BORNINO

  • Director
770,952 2010-02-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MCHUGH JULIE - Director

2021-04-22 16:02:23 -0400 2021-04-20 A 2,500 a 125,607 direct

MCCOURT THOMAS A - Officer PRESIDENT AND INTERIM CEO

2021-03-30 17:07:38 -0400 2021-03-26 A 96,638 a 568,215 direct -2.6834 -7.5134 0.0 1 -7.5134 6

SHETZLINE MICHAEL - Officer CMO, SVP & HEAD OF DRUG DEVT.

2021-03-30 17:09:56 -0400 2021-03-26 A 38,655 a 199,514 direct -2.6834 -7.5134 0.0 1 -7.5134 6

CONSYLMAN GINA - Officer SVP, CFO & TREASURER

2021-03-30 17:06:12 -0400 2021-03-26 A 56,372 a 392,616 direct -2.6834 -7.5134 0.0 1 -7.5134 6

RICKARD JASON - Officer SVP, CHIEF OPERATING OFFICER

2021-03-30 17:08:41 -0400 2021-03-26 A 56,372 a 363,054 direct -2.6834 -7.5134 0.0 1 -7.5134 6

MOUKHEIBIR CATHERINE - Director

2021-03-17 16:01:22 -0400 2021-03-15 A 1,573 a 48,994 direct 0.2674 -2.7629 2.6738 3 -5.5258 5

DENNER ALEXANDER J - Director - > 10% Owner

SARISSA CAPITAL MANAGEMENT LP - > 10% Owner

2021-03-17 16:08:48 -0400 2021-03-15 A 1,235 a 39,079 direct 0.2674 -2.7629 2.6738 3 -5.5258 5

DREYFUS ANDREW - Director

2021-03-17 16:03:53 -0400 2021-03-15 A 1,460 a 109,097 direct 0.2674 -2.7629 2.6738 3 -5.5258 5

DENNER ALEXANDER J - Director - > 10% Owner see footnote

SARISSA CAPITAL MANAGEMENT LP - Director - > 10% Owner see footnote

2021-03-10 19:06:57 -0500 2021-03-10 P 75,000 $10.54 a 16,390,000 indirect 0.4885 -0.3552 2.3979 5 -1.1989 3

DENNER ALEXANDER J - Director - > 10% Owner see footnote

SARISSA CAPITAL MANAGEMENT LP - Director - > 10% Owner see footnote

2021-03-10 19:06:57 -0500 2021-03-08 P 150,000 $10.30 a 16,315,000 indirect 0.4885 -0.3552 2.3979 5 -1.1989 3

DENNER ALEXANDER J - Director - > 10% Owner see footnote

SARISSA CAPITAL MANAGEMENT LP - Director - > 10% Owner see footnote

2021-03-05 19:19:46 -0500 2021-03-05 P 175,000 $10.01 a 16,165,000 indirect 7.4437 8.9618 4.4074 12.9285 8 -0.4897 25

DENNER ALEXANDER J - Director - > 10% Owner see footnote

SARISSA CAPITAL MANAGEMENT LP - Director - > 10% Owner see footnote

2021-03-05 19:19:46 -0500 2021-03-04 P 250,000 $10.00 a 15,990,000 indirect 7.4437 8.9618 4.4074 12.9285 8 -0.4897 25

DENNER ALEXANDER J - Director - > 10% Owner see footnote

SARISSA CAPITAL MANAGEMENT LP - Director - > 10% Owner see footnote

2021-03-05 19:19:46 -0500 2021-03-03 P 350,000 $10.02 a 15,740,000 indirect 7.4437 8.9618 4.4074 12.9285 8 -0.4897 25

DENNER ALEXANDER J - Director see footnote

2021-03-02 20:18:07 -0500 2021-03-02 P 500,000 $9.56 a 15,390,000 indirect 0.2006 5.8175 8.7262 15.6469 11 0.0 1

DENNER ALEXANDER J - Director see footnote

2021-03-02 20:18:07 -0500 2021-03-01 P 344,900 $9.60 a 14,890,000 indirect 0.2006 5.8175 8.7262 15.6469 11 0.0 1

DENNER ALEXANDER J - Director see footnote

2021-03-02 20:18:07 -0500 2021-02-26 P 505,100 $9.20 a 14,545,100 indirect 0.2006 5.8175 8.7262 15.6469 11 0.0 1

RICKARD JASON - Officer SVP, CHIEF OPERATING OFFICER

2021-03-02 16:43:50 -0500 2021-02-26 S 6,159 $9.11 d 306,682 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

RICKARD JASON - Officer SVP, CHIEF OPERATING OFFICER

2021-03-02 16:43:50 -0500 2021-02-26 S 2,668 $9.11 d 317,665 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

MCCOURT THOMAS A - Officer PRESIDENT

2021-03-02 16:40:18 -0500 2021-02-26 S 1,838 $9.11 d 481,842 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

MALLON MARK - Director - Officer CHIEF EXECUTIVE OFFICER

2021-03-02 16:37:55 -0500 2021-02-26 S 8,093 $9.11 d 493,187 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

KILROY CONOR - Officer SVP, GC & SECRETARY

2021-03-02 16:36:27 -0500 2021-02-26 S 1,474 $9.11 d 126,452 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

CONSYLMAN GINA - Officer SVP, CFO & TREASURER

2021-03-02 16:34:50 -0500 2021-02-26 S 6,242 $9.11 d 343,224 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

SHETZLINE MICHAEL - Officer CMO, SVP & HEAD OF DRUG DEVT.

2021-03-02 16:44:58 -0500 2021-02-26 S 3,041 $9.11 d 160,859 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

RICKARD JASON - Officer SVP, CHIEF OPERATING OFFICER

2021-03-02 16:43:50 -0500 2021-02-26 S 3,197 $9.11 d 312,841 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

OWENS EDWARD P - Director

2021-03-02 16:41:41 -0500 2021-02-26 P 3,000 $8.90 a 218,954 direct 0.2006 5.8175 8.7262 15.6469 11 0.0 1

MCCOURT THOMAS A - Officer PRESIDENT

2021-03-02 16:40:18 -0500 2021-02-26 S 2,582 $9.11 d 483,680 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

KILROY CONOR - Officer SVP, GC & SECRETARY

2021-03-02 16:36:27 -0500 2021-02-26 S 1,848 $9.11 d 122,336 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

KILROY CONOR - Officer SVP, GC & SECRETARY

2021-03-02 16:36:27 -0500 2021-02-26 S 1,399 $9.11 d 127,926 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

CONSYLMAN GINA - Officer SVP, CFO & TREASURER

2021-03-02 16:34:50 -0500 2021-02-26 S 2,527 $9.11 d 349,466 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

SHETZLINE MICHAEL - Officer CMO, SVP & HEAD OF DRUG DEVT.

2021-03-02 16:44:58 -0500 2021-02-26 S 1,398 $9.11 d 163,900 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

RICKARD JASON - Officer SVP, CHIEF OPERATING OFFICER

2021-03-02 16:43:50 -0500 2021-02-26 S 1,627 $9.11 d 316,038 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

MCCOURT THOMAS A - Officer PRESIDENT

2021-03-02 16:40:18 -0500 2021-02-26 S 10,265 $9.11 d 471,577 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

MALLON MARK - Director - Officer CHIEF EXECUTIVE OFFICER

2021-03-02 16:37:55 -0500 2021-02-26 S 22,582 $9.11 d 470,605 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

KILROY CONOR - Officer SVP, GC & SECRETARY

2021-03-02 16:36:27 -0500 2021-02-26 S 2,268 $9.11 d 124,184 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

CONSYLMAN GINA - Officer SVP, CFO & TREASURER

2021-03-02 16:34:50 -0500 2021-02-26 S 6,980 $9.11 d 336,244 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

CONSYLMAN GINA - Officer SVP, CFO & TREASURER

2021-03-02 16:34:50 -0500 2021-02-26 S 2,657 $9.11 d 351,993 direct yes 0.2006 5.8175 8.7262 15.6469 11 0.0 1

OWENS EDWARD P - Director

2021-02-26 17:15:52 -0500 2021-02-25 P 5,000 $9.11 a 215,954 direct -0.6257 6.4651 7.5078 20.2294 13 -0.6257 2

OWENS EDWARD P - Director

2021-02-26 17:15:52 -0500 2021-02-24 P 7,000 $9.26 a 210,954 direct -0.6257 6.4651 7.5078 20.2294 13 -0.6257 2

CONSYLMAN GINA - Officer SVP, CFO & TREASURER

2021-02-24 16:02:01 -0500 2021-02-22 A 84,951 a 354,650 direct 2.1018 10.5088 12.7212 27.5442 15 0.0 1

RICKARD JASON - Officer SVP, CHIEF OPERATING OFFICER

2021-02-24 16:11:56 -0500 2021-02-22 A 84,951 a 320,333 direct 2.1018 10.5088 12.7212 27.5442 15 0.0 1

MCCOURT THOMAS A - Officer PRESIDENT

2021-02-24 16:07:13 -0500 2021-02-22 A 145,631 a 486,262 direct 2.1018 10.5088 12.7212 27.5442 15 0.0 1

SHETZLINE MICHAEL - Officer CMO, SVP & HEAD OF DRUG DEVT.

2021-02-24 16:17:52 -0500 2021-02-22 A 58,252 a 165,298 direct 2.1018 10.5088 12.7212 27.5442 15 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-23 14:45:03 UTC -0.2529 0.3129 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-23 14:15:03 UTC -0.2529 0.3129 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-23 13:45:03 UTC -0.2529 0.3129 850000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-23 13:15:03 UTC -0.2529 0.3129 850000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-23 12:45:02 UTC -0.2529 0.3129 850000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 22:15:03 UTC -0.2529 0.3129 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 21:45:04 UTC -0.2217 0.2817 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 21:15:03 UTC -0.2217 0.2817 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 20:45:03 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 20:15:03 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 19:45:02 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 19:15:03 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 18:45:02 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 18:15:03 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 17:45:02 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 17:15:03 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 16:45:03 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 16:15:02 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 15:45:03 UTC -0.19 0.25 900000
IRONWOOD PHARMACEUTICALS INC IRWD 2021-04-22 15:15:03 UTC -0.19 0.25 900000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Diversified Arbitrage Fund IRWD -133806.0 shares, $-1524050.34 2020-12-31 N-PORT
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund IRWD -89481.0 shares, $-1030821.12 2020-11-30 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio IRWD -10499.0 shares, $-119583.61 2020-12-31 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund IRWD -74479.0 shares, $-848315.81 2020-12-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund IRWD -13.0 shares, $-131.17 2020-03-31 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund IRWD -1005487.0 shares, $-10276077.14 2021-01-31 N-PORT

Elevate your investments